Reversible cerebral vasoconstriction syndrome in a methylphenidate-treated patient: a case report

CONCLUSIONS: The role of methylphenidate needs to be considered in case of RCVS diagnosis observed in a treated patient. Although the frequency of this potential adverse drug reaction is expected to be rare, clinicians should be aware of its possible occurrence, given the ever-increasing use of methylphenidate.

via https://pubmed.ncbi.nlm.nih.gov/39736535/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250108010905&v=2.18.0.post9+e462414